Literature DB >> 18773989

Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality.

John S Ho1, John J Cannaday, Carolyn E Barlow, Tedd L Mitchell, Kenneth H Cooper, Shannon J FitzGerald.   

Abstract

The metabolic syndrome (MS) is a constellation of risk factors associated with diabetes and cardiovascular disease. This syndrome consists of at least 3 parameters assessing central obesity, hypertension, high-density lipoprotein cholesterol, triglycerides, and impaired glucose metabolism. Whether persons with 4 or 5 risk factors are at higher risk than those with 3 risk factors is unclear. Also unclear is whether those without the MS but with 1 or 2 risk factors warrant therapy. We assessed cardiovascular and all-cause mortality as a function of the number of these risk factors. We followed 30,365 men for a median follow-up of 13.6 years. During follow-up, 1,449 participants died, 527 from cardiovascular causes. All of the individual parameters defining the MS were significantly associated with both all-cause and cardiovascular mortality (p <0.001). After adjustment for age and the other MS variables, hypertension was the most potent risk factor whereas central obesity and hypertriglyceridemia remained associated with both all-cause and cardiovascular mortality. A highly significant trend was also noted between both all-cause or cardiovascular mortality and the number of risk factors (p <0.001 for trend). Risk increased incrementally, beginning at 1 risk factor for cardiovascular mortality and at 2 risk factors for all-cause mortality. In conclusion, there is a continuum of risk as the number of metabolic syndrome risk factors increases. These findings add to the growing evidence that central obesity can independently and adversely affect health.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773989     DOI: 10.1016/j.amjcard.2008.05.010

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

1.  Obstructive sleep apnea syndrome is associated with metabolic syndrome and inflammation.

Authors:  Qi-Chang Lin; Li-Da Chen; Yao-Hua Yu; Kai-Xiong Liu; Shao-Yong Gao
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-31       Impact factor: 2.503

2.  A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea.

Authors:  Neus Salord; Ana Maria Fortuna; Carmen Monasterio; Mercè Gasa; Antonio Pérez; Maria R Bonsignore; Núria Vilarrasa; Josep Maria Montserrat; Mercedes Mayos
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

Review 3.  Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.

Authors:  Brian D Kent; Walter T McNicholas; Silke Ryan
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

4.  Prevalence of undiagnosed and inadequately treated type 2 diabetes mellitus, hypertension, and dyslipidemia in morbidly obese patients who present for bariatric surgery.

Authors:  Rouzbeh Mostaedi; Denise E Lackey; Sean H Adams; Stephen A Dada; Zahid A Hoda; Mohamed R Ali
Journal:  Obes Surg       Date:  2014-06       Impact factor: 4.129

5.  The interaction between apolipoprotein B insertion/deletion polymorphism and macronutrient intake on lipid profile and serum leptin and ghrelin levels in type 2 diabetes mellitus patients.

Authors:  Masoumeh Rafiee; Gity Sotoudeh; Mahmoud Djalali; Ehsan Alvandi; Mohammadreza Eshraghian; Fatemeh Javadi; Farideh Doostan; Fariba Koohdani
Journal:  Eur J Nutr       Date:  2018-01-27       Impact factor: 5.614

Review 6.  Update on the metabolic syndrome: hypertension.

Authors:  Kristi Reynolds; Rachel P Wildman
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

7.  Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.

Authors:  Yoosoo Chang; Hyun-Suk Jung; Juhee Cho; Yiyi Zhang; Kyung Eun Yun; Mariana Lazo; Roberto Pastor-Barriuso; Jiin Ahn; Chan-Won Kim; Sanjay Rampal; Miguel Cainzos-Achirica; Di Zhao; Eun Cheol Chung; Hocheol Shin; Eliseo Guallar; Seungho Ryu
Journal:  Am J Gastroenterol       Date:  2016-05-17       Impact factor: 10.864

8.  COSEHC global vascular risk management quality improvement program: rationale and design.

Authors:  Carlos M Ferrario; Michael A Moore; William Bestermann; Chris Colby; Alex Exuzides; Debra Simmons; Sumeet Panjabi
Journal:  Vasc Health Risk Manag       Date:  2010-12-13

9.  Weight Gain Associated With Integrase Stand Transfer Inhibitor Use in Women.

Authors:  Anne Marie Kerchberger; Anandi N Sheth; Christine D Angert; C Christina Mehta; Nathan A Summers; Ighovwerha Ofotokun; Deborah Gustafson; Sheri D Weiser; Anjali Sharma; Adaora A Adimora; Audrey L French; Michael Augenbraun; Jennifer Cocohoba; Seble Kassaye; Hector Bolivar; Usha Govindarajulu; Deborah Konkle-Parker; Elizabeth T Golub; Cecile D Lahiri
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

10.  Intra-abdominal fat area is a predictor for new onset of individual components of metabolic syndrome: MEtabolic syndRome and abdominaL ObesiTy (MERLOT study).

Authors:  Yoko M Nakao; Takashi Miyawaki; Shinji Yasuno; Kazuhiro Nakao; Sachiko Tanaka; Midori Ida; Masakazu Hirata; Masato Kasahara; Kiminori Hosoda; Kenji Ueshima; Kazuwa Nakao
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.